The Closer Trial: A Safety and Efficacy Study of the Rex Medical Vascular Sealing System
Public ClinicalTrials.gov record NCT02136004. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Closer Trial: A Multi-center, Prospective, Single Arm Trial to Evaluate the Safety and Efficacy of the Rex Medical Closer Vascular Sealing System (VSS) for the Management of the Femoral Arteriotomy After Percutaneous Endovascular Procedures
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this trial is to demonstrate the safety and effectiveness of the Rex Medical Closer Vascular Sealing System in sealing femoral arterial access sites.
Study identification
- NCT ID
- NCT02136004
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 220 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2014 (Type not available)
- Primary completion
- Feb 2015 (Actual)
- Completion
- Feb 2015 (Actual)
- Last update posted
- Oct 27, 2017
2014 – 2015
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UC Davis Medical Center | Sacramento | California | 95817 | — |
| Colorado Neurological Institute | Englewood | Colorado | 80113 | — |
| Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Lafayette General Medical Center/Cardiovascular Institute of the South | Lafayette | Louisiana | 70503 | — |
| New York Presbyterian Hospital | New York | New York | 10065 | — |
| North Ohio Research | Elyria | Ohio | 44035 | — |
| Oklahoma Heart Institute | Tulsa | Oklahoma | 74104 | — |
| Oregon Health & Science University | Portland | Oregon | 97239-3098 | — |
| Geisinger Health Center | Danville | Pennsylvania | 17822 | — |
| Geisinger Health Center | Wilkes-Barre | Pennsylvania | 18711 | — |
| Pinnacle Health | Wormleysburg | Pennsylvania | 17043 | — |
| Heart Hospital of Austin | Austin | Texas | 78756 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02136004, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 27, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02136004 live on ClinicalTrials.gov.